Results 41 to 50 of about 54,777 (206)

Effects of a Human Papilloma Virus (HPV) Prevention Education among Girls in 6 Grade Elementary School, South Korea

SAGE Open, 2023
Studies on human papillomavirus (HPV) prevention education and its educational effects for elementary school students are necessary. This study aimed to examine the effects of human papillomavirus (HPV) prevention education on knowledge about cervical ...
Jeon Hee Kim, Soonyoung Park, Youngmi Cho, Sohyune Sok   +3 more
doaj   +1 more source

An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy

Frontiers in Immunology, 2022
Human papillomavirus (HPV) is the most common sexually transmitted agent worldwide. Early prevention with HPV vaccination is a safe and effective method against this disease.
Zahra Yousefi, Hamid Aria, Farhoodeh Ghaedrahmati, Tahereh Bakhtiari, Mahdieh Azizi, Reza Bastan, Reza Hosseini, Nahid Eskandari   +7 more
doaj   +1 more source

Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis [PDF]

, 2019
Background More than 10 years have elapsed since human papillomavirus (HPV) vaccination was implemented. We did a systematic review and meta-analysis of the population-level impact of vaccinating girls and women against human ...
\uc9lodie, B\ue9nard, A Kahn, Jessica, A Machalek, Dorothy, A Smith, Megan, Ali, Hammad, Baldo, Vincenzo, Boily, MarcMarie\uadClaude, Brassard, Paul, Brisson,, Callander, Denton, Checchi, Marta, Cocchio, Silvia, Dalianis, Tina, Dehlendorff, Christian, Donovan, Basil, F Chow, Eric P, G Pollock, Kevin, Gr\ufcn, Nathalie, Harrison, Christopher, Herweijer, Eva, J Woestenberg, Petra, Jes\ufas Purri\uf1os\uadHermida, Mar\ueda, K Fairley, Christopher, K Kjaer, Susanne, Kavanagh, Kimberley, L Brotherton, Julia M, L Deeks, Shelley, Liu, Bette, M Garland, Suzanne, M Imburgia, Teresa, M Johnson, Anne, M Wheeler, Cosette, M\ue9lanie, Drolet, Markowitz, Lauri, Mesher, David, Munk, Christian, Niccolai, Linda, Norma, P\ue9rez, Nyg\ue5rd, Mari, Ogilvie, Gina, Oliphant, Jeannie, S\uf6derlund\uadStrand, Anna, Sonnenberg, Pam, Sparen, P\ue4r, Steben, Marc, T Hansen, Bo, Tanton, Clare, V Kliewer, Erich, W Flagg, Elaine, W Gargano, Julia, Yu., Bo Nancy   +50 more
core   +2 more sources

Knowledge among college students and employees of local health units about human papillomavirus and cervical cancer and its implications for public health strategies and vaccination

DST, 2022
Introduction: Human papillomavirus (HPV) is the most commonly diagnosed sexually transmitted infection worldwide. It is estimated that 70% of cervical cancer cases are related to high-risk HPV 16 and 18 types; and 90% of genital warts to HPV 6 and 11 ...
Edison Natal Fedrizzi, Walkíria Rodrigues de Freitas, Fabiana Gonçalves de Aguiar   +2 more
doaj  

Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development

Frontiers in Immunology, 2022
Licensed L1-VLP-based immunizations against high-risk mucosal human papillomavirus (HPV) types have been a great success in reducing anogenital cancers, although they are limited in their cross-protection against HPV types not covered by the vaccine ...
Melinda Ahmels, Filipe C. Mariz, Ilona Braspenning-Wesch, Sonja Stephan, Bettina Huber, Gabriele Schmidt, Rui Cao, Martin Müller, Reinhard Kirnbauer, Frank Rösl, Daniel Hasche   +10 more
doaj   +1 more source

Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction [PDF]

, 2018
PURPOSE: The aims of this study were to determine prevalence of and factors associated with any human papillomavirus (HPV) and vaccine-type HPV among young men after vaccine introduction, stratified by vaccination status.
Bernstein, David I., Brown, Darron A., Chandler, Emmanuel, Ding, Lili, Franco, Eduardo L., Gorbach, Pamina, Kahn, Jessica A., Widdice, Lea E.   +7 more
core   +1 more source

Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation.

PLoS ONE
Human papillomavirus 16 and human papillomavirus 18 have been associated with different life-threatening cancers, including cervical, lung, penal, vulval, vaginal, anal, and oropharyngeal cancers, while cervical cancer is the most prominent one.
Md Mijanur Rahman, Md Habib Ullah Masum, Rehana Parvin, Shuvo Chandra Das, Asma Talukder   +4 more
doaj   +1 more source

Association between parent attitudes and receipt of human papillomavirus vaccine in adolescents

BMC Public Health, 2017
Background Human papillomavirus (HPV) vaccine coverage rates remain low. This is believed to reflect parental hesitancy, but few studies have examined how changes in parents’ attitudes impact HPV vaccine uptake.
Jeffrey J. VanWormer, Casper G. Bendixsen, Elizabeth R. Vickers, Shannon Stokley, Michael M. McNeil, Julianne Gee, Edward A. Belongia, Huong Q. McLean   +7 more
doaj   +1 more source

Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs

Frontiers in Oncology, 2022
Human papillomavirus (HPV) contributes to sexually transmitted infection, which is primarily associated with pre-cancerous and cancerous lesions in both men and women and is among the neglected cancerous infections in the world.
Rahul Bhattacharjee, Lamha Kumar, Archna Dhasmana, Tamoghni Mitra, Abhijit Dey, Sumira Malik, Bonglee Kim, Rohit Gundamaraju   +7 more
doaj   +1 more source

Human Papillomavirus Vaccination – A Moment of Prevention, a Lifetime of Protection

Indian Journal of Public Health
Human papillomavirus (HPV) vaccination is the primary preventive strategy to reduce the burden of cervical cancer as well as other HPV-related malignancies.
Priya Abraham
doaj   +1 more source